Intellia Therapeutics (NTLA) has a market capitalization of $2.7B, based on 111.46M shares at a price of $24.52 (down 4.3% yesterday).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
October 2025 | $24.52 | 64,124,525 | 111,462,139 | $2,733,051,648.28 |
September 2025 | $17.27 | 134,821,200 | 103,732,000 | $1,791,451,640.00 |
August 2025 | $11.36 | 91,433,741 | 103,732,000 | $1,177,876,860.00 |
July 2025 | $11.64 | 107,857,813 | 103,732,000 | $1,207,440,480.00 |
June 2025 | $9.38 | 100,282,471 | 103,732,000 | $973,006,160.00 |
May 2025 | $6.87 | 101,549,846 | 103,732,000 | $712,638,840.00 |
April 2025 | $8.87 | 74,292,174 | 103,732,000 | $920,102,840.00 |
March 2025 | $7.11 | 70,365,266 | 103,500,000 | $735,885,000.00 |
February 2025 | $10.09 | 65,687,345 | 103,500,000 | $1,044,315,000.00 |
January 2025 | $10.32 | 62,904,114 | 103,500,000 | $1,068,120,000.00 |
December 2024 | $11.66 | 48,687,870 | 101,855,000 | $1,187,629,300.00 |
November 2024 | $15.62 | 57,631,498 | 101,855,000 | $1,590,975,100.00 |
October 2024 | $14.22 | 61,103,382 | 101,855,000 | $1,448,378,100.00 |
September 2024 | $20.55 | 29,416,670 | 101,002,000 | $2,075,591,100.00 |
August 2024 | $22.44 | 25,879,057 | 101,002,000 | $2,266,484,880.00 |
July 2024 | $26.21 | 33,227,928 | 101,002,000 | $2,647,262,420.00 |
June 2024 | $22.38 | 39,769,016 | 96,975,000 | $2,170,300,500.00 |
May 2024 | $21.38 | 32,829,177 | 96,975,000 | $2,073,325,500.00 |
April 2024 | $21.40 | 26,633,270 | 96,975,000 | $2,075,265,000.00 |
March 2024 | $27.51 | 26,889,653 | 95,502,000 | $2,627,260,020.00 |
February 2024 | $32.12 | 39,858,641 | 95,502,000 | $3,067,524,240.00 |
January 2024 | $23.82 | 29,710,749 | 95,502,000 | $2,274,857,640.00 |
December 2023 | $30.49 | 31,491,393 | 90,461,000 | $2,758,155,890.00 |
November 2023 | $29.63 | 35,316,398 | 90,461,000 | $2,680,359,430.00 |
October 2023 | $25.05 | 26,787,932 | 90,461,000 | $2,266,048,050.00 |
